ICD-10 code F71: Moderate intellectual disabilities
ICD-10 Code F71 covers moderate intellectual disabilities (IQ 35–49). Diagnost...
July 6, 2026
Key Takeaways
ICD-10 Code M31.9 identifies necrotizing vasculopathy, unspecified, within the systemic connective tissue disorders chapter (M30-M36).
M31.9 is a billable, specific ICD-10-CM code valid for FY2026 reimbursement claims with dates of service on or after October 1, 2015.
Use M31.9 only when clinical documentation does not support a more specific M31.x code; down-coding from a specific vasculopathy diagnosis increases audit risk.
M31.9 maps to HCC Category 108 (Vascular Disease) with a Risk Adjustment Factor of 0.296, making precise documentation critical for risk-adjusted reimbursement.
ICD-10 Code M31.9: Definition and clinical description
Most vasculitis cases reaching a coder’s desk arrive with incomplete diagnostic specificity. When the attending physician documents “necrotizing vasculopathy” without further qualification, ICD-10 Code M31.9 is the appropriate capture code. It is the residual “unspecified” slot in the M31 category, valid for FY2026 reimbursement under claims management software workflows.
Necrotizing vasculopathy refers to a group of inflammatory conditions in which vessel wall destruction leads to ischemia and tissue necrosis. The M31 category covers conditions not classified elsewhere in the M30 (polyarteritis nodosa) or M32 (systemic lupus erythematosus) ranges. According to the WHO ICD-10 browser, M31 captures conditions characterized by necrotizing inflammation of blood vessel walls, differentiating them from non-necrotizing vasculitides.
This article covers the M31.9 code hierarchy, billability status, HCC risk adjustment implications, documentation requirements, and the key decision points that separate M31.9 from its more specific siblings. Rheumatologists, internists, and medical coders in specialty and private practice settings will find the practical workflow guidance most relevant.
Code classification and hierarchy
Understanding where M31.9 sits within the ICD-10-CM structure prevents misclassification and protects reimbursement accuracy. The full hierarchy is straightforward once mapped out.
The M31 category is distinct from M30 (polyarteritis nodosa and related conditions), which covers classic polyarteritis nodosa and Kawasaki disease. M31 gathers the “other” necrotizing presentations. Where vessel involvement is the primary concern, coders should confirm the documented condition maps to a more specific vascular chapter before using M31.9.
Billable status and effective date
M31.9 is a billable/specific ICD-10-CM code. Claims with dates of service on or after October 1, 2015, require ICD-10-CM codes, and M31.9 has remained a valid, reimbursable code through FY2026. Check current status against the CDC/NCHS ICD-10-CM web tool before billing — annual updates may revise code validity.
ICD-10 Code M31.9 vs more specific M31 codes
M31.9 is a residual code by design. Before assigning it, coders must determine whether the clinical documentation supports a more specific M31.x alternative. Assigning M31.9 when a specific code is available exposes claims to down-coding on audit.
- M31.0 Hypersensitivity angiitis: Use when the documented condition is hypersensitivity or leukocytoclastic angiitis. Documentation must identify the hypersensitivity mechanism.
- M31.10 Thrombotic microangiopathy, unspecified: Appropriate when TMA is documented without specification of type (TTP vs HUS vs other).
- M31.19 Other thrombotic microangiopathy: Use for drug-induced TMA, complement-mediated TMA, or other specified TMA not classified at M31.10.
- M31.30 Wegener’s granulomatosis without renal involvement / M31.31 with renal involvement: Granulomatosis with polyangiitis (GPA) has dedicated codes; M31.9 is never appropriate when GPA is documented.
- M31.5 Giant cell arteritis with polymyalgia rheumatica / M31.6 Other giant cell arteritis: Both supersede M31.9 when giant cell arteritis is confirmed.
- M31.8 Other specified necrotizing vasculopathies: Used for named vasculopathy entities that do not have their own dedicated code, but where the type is still specified in documentation.
- M31.9 Necrotizing vasculopathy, unspecified: Reserved for cases where documentation genuinely cannot support any more specific classification.
The ICD-10-CM Official Guidelines for Coding and Reporting, maintained by the Centers for Medicare and Medicaid Services (CMS), instruct coders to use unspecified codes only when documentation does not support a more specific selection. Querying the treating physician before defaulting to M31.9 is best practice.
Pro Tip
Before assigning M31.9, review the clinical notes for any named vasculitis type, ANCA serology results, biopsy pathology, or organ involvement. GPA, MPA, EGPA, giant cell arteritis, and TTP each have dedicated M31 codes. A coder query returning even a qualifier like ‘likely GPA’ changes the appropriate code and can improve HCC risk adjustment accuracy.
HCC risk adjustment: what M31.9 means for reimbursement
Risk adjustment is where the financial stakes of precise coding become concrete. Both M31.8 and M31.9 map to HCC Category 108 (Vascular Disease) under the CMS HCC Risk Adjustment Model, carrying a Risk Adjustment Factor (RAF) of approximately 0.296 (verify against the current model year via the HCC ICD-10 crosswalk tool).
A RAF of 0.296 adds meaningful weight to a patient’s risk score. For Medicare Advantage plans, this translates directly into adjusted capitation payments. Under-documenting or under-coding means the plan receives less revenue to manage genuinely complex, high-cost patients.
